Comparison of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors and ovarian cancer patients

Author： Ingersoll Susan Blaydes   Stoltzfus Gregory P.   Merchant Mohammed H.   Ahmad Sarfraz   Edwards Collin R.   Ahmed Ahad   Oyer Jeremiah L.   Finkler Neil J.   Holloway Robert W.   Edwards John R.  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.14, Iss.6, 2012-07, pp. : 716-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ex vivo expansion of neutrophil precursor cells from mobilized peripheral blood cells: similar results in cancer patients and normal donors

By De Bruyn C   Delforge A   Martiat P   Bron D  

Cytotherapy, Vol. 7, Iss. 6, 2005-12 ,pp. : 470-477

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Gamma delta T cells from HIV++ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity

By Poonia Bhawna   Pauza C. David  

Cytotherapy, Vol. 14, Iss. 2, 2012-02 ,pp. : 173-181

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors

By McGuire TR   Kessinger A   Hock L   Sharp JG  

Cytotherapy, Vol. 3, Iss. 5, 2001-09 ,pp. : 361-364

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed

By Wiedswang G   Borgen E   Karesen R   Naume B  

Cytotherapy, Vol. 5, Iss. 1, 2003-01 ,pp. : 40-45

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer

By Rancourt C   Bergeron C   Lane D   Garon G   Piché A  

Cytotherapy, Vol. 5, Iss. 6, 2003-12 ,pp. : 509-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite